A pilot study was designed to examine whether the outcome of embryo transfer in women with a hydrosalpinx might be improved by surgical drainage of the hydrosalpinx at the time of oocyte collection for in-vitro fertilization treatment. A comparative, controlled but retrospective analysis of the results was performed of all women with infective tubal damage aged <40 years old, who had ovulatory cycles, a normal uterus and a partner with normal spermatozoa. A standardized treatment regimen was used. A maximum of three embryos were transferred. Hydrosalpinx was defined by prior hysterosalpingography and/or laparoscopy with transcervical dye injection. A total of 237 embryo transfer cycles in women with hydrosalpinges (tubal distension not visible in 151, visible but not drained in 30 and drained in 56) were compared with 705 embryo transfer cycles in women with tubal disease but no hydrosalpinx. Results were analysed in the first three cycles but also separately in the first cycle to check for bias. Success rates were higher in the first cycle, but did not significantly influence overall differences. Implantation rates were significantly reduced overall in the hydrosalpinx group (8.0 versus 13.2% for controls; P < 0.001), being 8.3% (P < 0.01) in the subgroup without evident tubal distension and 7.5% (not significant) in the drained hydrosalpinx group. This study shows that tubal damage with distal occlusion is associated with a marked reduction in embryo implantation, even in the absence of obvious fluid distension. Surgical drainage of distended hydrosalpinges appears to offer no benefit.
Introduction
In women with tubal infertility undergoing in-vitro fertilization (IVF) and embryo transfer treatment, the presence of a hydrosalpinx is associated with large reductions both in the implantation rate per embryo transferred and in the chance of pregnancy per cycle treatment (Anderson et al., 1994; Kassabji et al., 1994; Strandell et al., 1994; Vandromme et al., 1995; Akman et al., 1996; Fleming and Hull, 1996; Katz et al., 1996) . The underlying mechanism of this effect is speculative at present, but it may be caused by a toxic or displacing effect of hydrosalpinx fluid draining into the uterine cavity. For this reason, salpingectomy prior to starting IVF treatment has been suggested (Anderson et al., 1994; Strandell et al., 1994; Shelton et al., 1996) . However, this is a radical and emotionally difficult step for any couple to take. The more conservative surgical approach of salpingostomy to achieve distal drainage is an alternative possibility, but laparoscopy or laparotomy is required and tubal patency may not be maintained. The true benefit of such surgery awaits randomized clinical trials.
Another approach would be transvaginal drainage of the hydrosalpinx under ultrasound guidance. This can be undertaken easily and conveniently at the time of oocyte recovery and, if effective and safe, would be more attractive for its simplicity. Although reported previously (Aboulghar et al., 1990; Russell et al., 1991; Shahara et al., 1996) , this option has not been evaluated in any controlled way. Here we present a preliminary retrospective study of our treatment results compared with relevant control groups to assess whether this procedure is likely to be of any benefit.
Materials and methods
All women with tubal/pelvic infective damage as their sole cause of infertility who underwent IVF treatment at the University of Bristol IVF Service at the BUPA Hospital, Bristol, UK during the 5 years from January 1991 to September 1996 were studied. The women were all aged Ͻ40 years and had normal ovulatory cycles, normal basal gonadotrophin concentrations and a normal uterus, indicated by hysterosalpingography and transvaginal ultrasonography. The men all had normal sperm function.
In all women tubal status and the presence or absence of a hydrosalpinx were evaluated prior to IVF treatment using laparoscopy and/or hysterosalpingography. The definition of a hydrosalpinx was complete distal occlusion of one or both Fallopian tubes with abnormal distension of the ampullary portion of the tube before or after the injection of dye through the cervix. The diameter of the hydrosalpinx and the presence or absence of associated peritubal adhesions were not analysed.
Women with tubal disease but without a hydrosalpinx acted as controls. Those with previous salpingectomy or tubal sterilization were excluded from the control group. The hydrosalpinx group was later sub-classified into three groups according to the ultrasound findings at the time of oocyte collection for IVF treatment: (i) those in whom the hydrosalpinx was not seen on ultrasonography at that time ('not seen' group); (ii) those in whom the hydrosalpinx was seen on ultrasonography at that time but was not drained ('not drained' group); and (iii) those in whom the hydrosalpinx was seen and drained transvaginally at that time ('drained' group).
A hydrosalpinx was usually drained if there was obvious distension with fluid, but not if access seemed difficult or other structures were endangered. IVF treatment was undertaken using a standardized treatment protocol of pituitary desensitization, ovarian stimulation and embryo culture methods, as described previously (Hull et al., 1992) . A maximum of three embryos were transferred. Ultrasound-guided oocyte recovery was undertaken using a singleor double-channel needle (Casmed UK, Cheam, UK). Drainage of a hydrosalpinx was undertaken immediately after oocyte collection using the same needle. Fluid was sent for cytology and microscopy, and prophylactic i.v. single-dose antibiotic treatment was given.
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Prophylactic antibiotics were not administered routinely if drainage was not undertaken.
Fertilization and cleavage were defined as a single entity by the formation of a normal two-pronuclear cleaving embryo suitable for transfer; rates were based on the total number of oocytes collected. Clinical pregnancy was defined as the presence of one or more intrauterine gestational sacs shown by ultrasonography 4 weeks after treatment. Ongoing pregnancy was defined as continuing beyond 16 weeks gestation. The clinical pregnancy and live birth or ongoing pregnancy rates were calculated per embryo transfer cycle. Multiple Effect of drainage of a hydrosalpinx on IVF outcome (Anderson et al., 1994; Kassabji et al., 1994; Strandell et al., 1994; Vandromme et al., 1995; Fleming and Hull, 1996; Katz et al., 1996; Shahara et al., 1996) Hydrosalpinx Absent Present births from the same pregnancy were counted as one. The implantation rate was defined by the number of intrauterine gestational sacs as a proportion of the number of embryos transferred. The live baby or ongoing fetal rate per embryo was defined on the same basis. Ectopic pregnancies were documented but not included in the pregnancy and implantation rates. To reduce bias, results from only the first three cycles of treatment for each couple were analysed. Furthermore, the key outcome measures were also compared in only the first cycle of oocyte collection in each case. Rates for all results were compared between the patient groups using the χ 2 test with Yate's continuity correction where there were small numbers involved. Measured variables were compared using the Mann-Whitney U-test or t-test as appropriate.
Results
There were 589 patients. Of 968 IVF cycles started, 942 reached embryo transfer, 237 in women with pretreatment evidence of a hydrosalpinx and 705 in the controls with no hydrosalpinx. In women with a hydrosalpinx, tubal distension was not seen in 151 cycles of IVF treatment, was seen but not drained in 30 cycles, and was seen and drained in 56 cycles. There was no febrile or infectious morbidity associated with surgical drainage or with oocyte collection in any group. Table I shows that there were no significant differences between any of the groups in the woman's age, proportion of cycles reaching oocyte collection, peak oestradiol concentrations, duration of stimulation, number of oocytes collected, fertiliza-2149 tion and cleavage rates, or the proportion of cycles reaching embryo transfer. The distribution of the number of cycles performed was different for the two groups, with the hydrosalpinx patients more frequently having more than one cycle of treatment. Therefore the final analysis of the results was limited to first cycles only (see below).
The results per embryo transfer are given in Table II . Although no fewer embryos were transferred in each cycle, the intrauterine and ongoing pregnancy rates in all the hydrosalpinx subgroups appeared to be substantially reduced, although this did not reach statistical significance. The overall ectopic pregnancy rate in the hydrosalpinx group (9.6%) appeared to be higher than in the non-hydrosalpinx group (3.4%), but inclusion of these cases in the analysis of pregnancy or implantation rates made no difference to the statistical conclusions.
The results per individual embryo transferred are given in Table III . The overall intrauterine implantation and live baby (or ongoing fetal) rates per embryo transferred were reduced significantly in the hydrosalpinx group (P Ͻ 0.001). Although the rates appeared to be equally low in all the hydrosalpinx subgroups, a significant reduction was reached in the 'not seen' subgroup, which was by far the largest.
To check for possible bias caused by declining pregnancy and implantation rates in successive cycles per couple, the outcome measures were also analysed in only the first cycle of oocyte collection in each case. The results given in Table IV demonstrate slightly higher rates of treatment success, but differences between the groups remained as in the overall analysis.
Discussion
Published studies of the outcome of IVF treatment for infertility caused by tubal damage have consistently revealed reductions in the rates of pregnancy and birth per cycle, and of implantation rates per embryo transferred, in the presence of a hydrosalpinx. When the published data are combined, as shown in Table V , the reductions are seen to be substantial and significant. Salpingectomy has been suggested as a means of preventing the adverse effects of hydrosalpinx fluid draining into the uterine cavity (Anderson et al., 1994; Strandell et al., 1994; Shelton et al., 1996) . Vaginal aspiration-drainage of a hydrosalpinx at the time of oocyte collection would be a much simpler, non-radical solution if effective. One report of five clinical pregnancies from 11 IVF cycles where this procedure was undertaken at the time of oocyte retrieval was encouraging (Shahara et al., 1996) . Therefore we undertook the present comparative controlled but retrospective analysis of our results as a preliminary step towards testing the hypothesis that transvaginal drainage of hydrosalpinges at the time of oocyte collection for IVF would be beneficial for the implantation of transferred embryos.
In our patients the diagnosis of hydrosalpinx was based on tubal filling and distension with dye injected through the cervix. However, at the time of ultrasonography for oocyte collection, the tubes were not obviously distended in 64% of cases. Nevertheless, the success rates per embryo transfer cycle in terms of intrauterine pregnancy (21.2%) and birth or ongoing pregnancy (16.6%) appeared to be lower in those cases than in controls who had tubal damage without a hydrosalpinx (pregnancy 27.9%, birth 23.5%), and the implantation rate per embryo (8.3 versus 13.2%; P Ͻ 0.001) and the live baby rate per embryo (6.7 versus 11.4%; P Ͻ 0.001) were highly significantly reduced. Those results were based on up to three cycles per couple, but they were also analysed in only the first cycle to check for bias. Although success rates were higher in the first cycle, this did not influence the significance of differences between groups (Table  IV) . A systematic search for evident tubal fluid at the time of oocyte collection was not made. However, it seems that only a little fluid collecting in the Fallopian tube is sufficient to lead to disruptive drainage into the uterine cavity, disturbing implantation.
In 56 cycles in which evident hydrosalpinges were drained at the time of oocyte collection, the rates of pregnancy (19.6%), birth or ongoing pregnancy (16.1%) and implantation (7.5%) appeared to be similar to those of the other hydrosalpinx subgroups, including that in which a hydrosalpinx was evident but not drained (30 cycles) (Tables II and III) . However, numbers in these other subgroups were much smaller than in the 'not seen' hydrosalpinx subgroup and the difference was not statistically significant compared with the control groups. The same applied to the results in only the first cycle of treatment (Table IV) .
A randomized and much larger study than ours would be required to demonstrate the effectiveness of the treatment to restore pregnancy and live birth rates compared with those obtained for controls: 150 cycles in each group if α is 0.05 and β is 0.20. Even larger numbers would be needed to demonstrate a smaller beneficial effect. It is possible that an arbitrary decision as to whether or not to drain an evident hydrosalpinx, sometimes for technical reasons, introduced bias against the non-drained group. On the other hand, the results were equally and significantly impaired in the group without evident tubal distension at the time of oocyte collection. It seems unlikely that a hydrosalpinx could be drained completely or remain so for long.
The only other comparative study of vaginal drainage of a hydrosalpinx concerned drainage that was performed even before starting the cycle of stimulation leading to IVF (Aboulghar et al., 1990) . Improved ovarian responsiveness was found, leading to more embryos being available for transfer, although the chance of implantation or pregnancy did not seem to be affected. Such a marked effect on ovarian function has not been found either in our study (Table I) or by others studying the effect of hydrosalpinx on IVF treatment (Anderson et al., 1994; Fleming and Hull, 1996) , although subtle impairment associated with pelvic inflammatory disease has been reported (Bowman et al., 1993) . It seems unlikely that the drainage of a hydrosalpinx long before IVF could be of any benefit to implantation, particularly as re-accumulation of fluid in the tubes and apparent drainage into the uterus, thus distending the uterine cavity, have been reported in several cases (Mansour et al., 1991) .
The explanation for failure to benefit from drainage of hydrosalpinges may not lie simply in incomplete drainage leaving some fluid to spill into the uterine cavity. Functional damage to the tube would leave the way open for the retrograde passage of transferred embryos, both increasing the risk of ectopic pregnancy, as observed, and possibly contributing by wastage of embryos to the observed reduction of intrauterine implantation. If that is an important mechanism causing reduced intrauterine implantation there would also be no benefit from undertaking distal salpingostomy simply to maintain tubal drainage.
In conclusion, our findings strongly suggest that transvaginal drainage of hydrosalpinges at the time of oocyte collection for IVF treatment would be of no benefit. They do not encourage the mounting of formal randomized studies but focus attention on the need to evaluate radical surgical solutions to the tubal problem.
